Lv5
1589 积分 2021-12-14 加入
Zongertinib in Previously Treated HER2 -Mutant Non–Small-Cell Lung Cancer
13小时前
待确认
Zongertinib in Previously Treated HER2 -Mutant Non–Small-Cell Lung Cancer
8天前
已完结
Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions
23天前
已完结
Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6): single-arm, open-label, multicentre, phase 2 trial
23天前
已完结
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
2个月前
已完结
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
2个月前
已完结
EP.04E.05 Prevalence and Characterization of MET Overexpression in Chinese NSCLC Patients: A Retrospective Real-World Analysis
2个月前
已关闭
Small-cell lung cancer
2个月前
已完结
Circulating Tumor DNA-Guided De-Escalation Targeted Therapy for Advanced Non−Small Cell Lung Cancer
2个月前
已完结
Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer
3个月前
已完结
皖公网安备34019202002308
